L-LEUCINE, O5-(N-FORMYL-L-LEUCYL)-(2S,3S,5S)-2-HEXYL-3,5-DIHYDROXYHEXADECANOYL-, (1S)-1-(((2S,3S)-3-HEXYL-4-OXO-2-OXETANYL)METHYL)DODECYL ESTER
UNII B2SHK4HZF5

Substance Identification & Data

This profile provides standardized clinical and technical data for L-leucine, O5-(n-formyl-l-leucyl)-(2s,3s,5s)-2-hexyl-3,5-dihydroxyhexadecanoyl-, (1s)-1-(((2s,3s)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl Ester, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B2SHK4HZF5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 881900-54-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
B2SHK4HZF5
CAS Registry Number
881900-54-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
L-LEUCINE, O5-(N-FORMYL-L-LEUCYL)-(2S,3S,5S)-2-HEXYL-3,5-DIHYDROXYHEXADECANOYL-, (1S)-1-(((2S,3S)-3-HEXYL-4-OXO-2-OXETANYL)METHYL)DODECYL ESTER
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C57H106N2O9
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
NVVMPRANOWJTRG-GAYSTJMUSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
CCCCCCCCCCC[C@@H](C[C@@H]([C@H](CCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)O[C@@H](CCCCCCCCCCC)C[C@H]1[C@H](CCCCCC)C(=O)O1)O)OC(=O)[C@H](CC(C)C)NC=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for L-leucine, O5-(n-formyl-l-leucyl)-(2s,3s,5s)-2-hexyl-3,5-dihydroxyhexadecanoyl-, (1s)-1-(((2s,3s)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl Ester. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

((7S,8S,10S)-7-(((2S)-1-((2S)-1-((2S,3S)-3-HEXYL-4-OXOOXETAN-2-YL)TRIDECAN-2-YL)OXY-4-METHYL-1-OXOPENTAN-2-YL)CARBAMOYL)-8-HYDROXYHENICOSAN-10-YL) (2S)-2-FORMAMIDO-4-METHYLPENTANOATE
L-LEUCINE, O5-(N-FORMYL-L-LEUCYL)-(2S,3S,5S)-2-HEXYL-3,5-DIHYDROXYHEXADECANOYL-, (1S)-1-(((2S,3S)-3-HEXYL-4-OXO-2-OXETANYL)METHYL)DODECYL ESTER